State Of Wisconsin Investment Board Crinetics Pharmaceuticals, Inc. Transaction History
State Of Wisconsin Investment Board
- $36.6 Billion
- Q1 2025
A detailed history of State Of Wisconsin Investment Board transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 63,555 shares of CRNX stock, worth $1.98 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
63,555
Previous 75,103
15.38%
Holding current value
$1.98 Million
Previous $3.84 Million
44.51%
% of portfolio
0.01%
Previous 0.01%
Shares
21 transactions
Others Institutions Holding CRNX
# of Institutions
235Shares Held
87MCall Options Held
40KPut Options Held
162K-
Vanguard Group Inc Valley Forge, PA9.31MShares$291 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA6.89MShares$215 Million0.05% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.24MShares$195 Million2.28% of portfolio
-
Black Rock Inc. New York, NY6.23MShares$194 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.11MShares$160 Million0.02% of portfolio
About Crinetics Pharmaceuticals, Inc.
- Ticker CRNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,752,800
- Market Cap $1.68B
- Description
- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...